Prajapati Asta Ratna, Scott Sion, Dima Alexandra L, Clark Allan, Taylor Jo, Wilson Jonathan, Bhattacharya Debi
Norfolk and Suffolk NHS Foundation NHS Trust, UK.
University of Leicester, UK.
J Affect Disord. 2025 Aug 1;382:462-470. doi: 10.1016/j.jad.2025.04.149. Epub 2025 Apr 24.
Medication nonadherence in bipolar disorder (BD) can lead to adverse outcomes including relapse, hospitalisation and suicidility. Adherence research traditionally excludes mental health populations and their family and friends, contributing to inequity between physical and mental health. We used behavioural science to characterise modifiable adherence determinants in BD from the perspectives of patients and their family and friends.
Between April-June 2020, we conducted two focus groups and 26 interviews with adults with BD and their family and friends. We explored modifiable adherence determinants which were mapped to the Theoretical Domains Framework (TDF), followed by a thematic analysis and prioritisation of determinants.
Sixty-three (including 13 new) adherence determinants, mapped to nine TDF domains, were prioritised. Four themes of adherence determinants emerged: the medication itself; practicalities; how patients perceive themselves, their illness, and treatments; and collaboration between patients, their family and friends, and healthcare professionals. Nine prioritised TDF domains were: 'Environmental context and resources', 'Intentions', 'Emotion', 'Social Influences', 'Goals', 'Memory, attention and decision processes', 'Beliefs about consequences', 'Knowledge' and 'Social/professional role and identity'. Respective examples include side effects, treatment preferences, fear of not being 'myself', relationships with healthcare team, medication affecting life goals, forgetfulness, beliefs about negative consequences, not knowing the risk of stopping medication, and involvement in treatment decisions.
Targeting antecedents of forgetfulness as well as newly identified determinants linked to 'Emotion' and 'Intentions', may improve adherence. Mapping adherence determinants to TDF domains provides a framework for designing personalised adherence interventions by selecting appropriate behaviour change techniques.
双相情感障碍(BD)患者的用药依从性差会导致不良后果,包括病情复发、住院和自杀倾向。传统的依从性研究将心理健康人群及其家人和朋友排除在外,加剧了心理健康与身体健康之间的不平等。我们运用行为科学从患者及其家人和朋友的角度,对双相情感障碍中可改变的依从性决定因素进行了特征描述。
在2020年4月至6月期间,我们对成年双相情感障碍患者及其家人和朋友进行了两组焦点小组讨论和26次访谈。我们探究了可改变的依从性决定因素,并将其映射到理论领域框架(TDF),随后进行了主题分析和决定因素的优先级排序。
确定了63个(包括13个新的)依从性决定因素,这些因素映射到9个TDF领域,并进行了优先级排序。出现了四个依从性决定因素主题:药物本身;实际情况;患者如何看待自己、疾病和治疗;以及患者与其家人、朋友和医疗保健专业人员之间的协作。九个优先级TDF领域为:“环境背景和资源”、“意图”、“情感”、“社会影响”、“目标”、“记忆、注意力和决策过程”、“对后果的信念”、“知识”以及“社会/专业角色和身份”。各自的例子包括副作用、治疗偏好、害怕失去“自我”、与医疗团队的关系、药物对生活目标的影响、健忘、对负面后果的信念、不知道停药的风险以及参与治疗决策。
针对健忘的前因以及新发现的与“情感”和“意图”相关的决定因素,可能会提高依从性。将依从性决定因素映射到TDF领域,为通过选择合适的行为改变技术设计个性化的依从性干预措施提供了一个框架。